NCT01852890 2025-10-24
Gemcitabine, Ascorbate, Radiation Therapy for Pancreatic Cancer, Phase I
University of Iowa
Phase 1 Completed
Clinical Trials
37 trialsNCT02905578 2025-08-27
A Phase 2 Trial of High-dose Ascorbate for Pancreatic Cancer (PACMAN 2.1)
University of Iowa
Phase 2 Completed
NCT01754987 2025-05-04
A Study of Vitamin C in the Treatment of Liver Cancer to Determine if it is Safe and Effective
Thomas Jefferson University
Phase 1/2 Completed
NCT01752491 2024-12-20
A Phase I Trial of High-Dose Ascorbate in Glioblastoma Multiforme
University of Iowa
Phase 1 Completed
NCT01905150 2024-12-11
Ph 2 Trial of Vitamin C & G-FLIP (Low Doses Gemcitabine, 5FU, Leucovorin, Irinotecan, Oxaliplatin) for Pancreatic Cancer
Bruckner Oncology
Phase 2 Completed
NCT02420314 2024-08-20
Pharmacological Ascorbate for Lung Cancer
University of Iowa
Phase 2 Completed
NCT03508726 2024-06-27
High Dose Ascorbate With Preoperative Radiation in Patients With Locally Advanced Soft Tissue Sarcomas
University of Iowa
Phase 1/2 Completed
NCT03146962 2024-05-02
High Dose Vitamin C Intravenous Infusion in Patients With Resectable or Metastatic Solid Tumor Malignancies
Weill Medical College of Cornell University
Phase 2 Completed
NCT05726097 2024-02-28
Bowel Preparation Regimen for Colon Capsule Endoscopy Procedure
Region Skane
Phase 3 Completed
NCT03613727 2023-11-07
Therapeutic Use of Intravenous Vitamin C in Allogeneic Stem Cell Transplant Recipients
Virginia Commonwealth University
Phase 2 Completed
NCT02206425 2023-10-31
Ixazomib as a Replacement for Carfilzomib and Bortezomib for Multiple Myeloma Patients
Oncotherapeutics
Phase 1/2 Completed
NCT02969681 2023-06-27
Vitality
Sun Yat-sen University
Phase 3 Completed
NCT03410030 2023-04-18
AA NABPLAGEM
HonorHealth Research Institute
Phase 1/2 Completed
NCT03964688 2022-04-20
VICAST
Maastricht University Medical Center
Phase 2 Completed
NCT01891747 2022-03-10
A Phase I Study of High-dose L-methylfolate in Combination With Temozolomide and Bevacizumab in Recurrent High Grade Glioma
Vanderbilt-Ingram Cancer Center
Phase 1 Completed
NCT04279535 2021-11-02
Topical Vitamin C for Treatment of Basal Cell Cancer
Center for Biomedical Research, Inc.
Phase EARLY_PHASE1 Completed
NCT03397173 2021-08-11
TET2 Mutations in Myelodysplastic Syndromes and Acute Myeloid Leukemia With Azacitidine + Ascorbic Acid
Case Comprehensive Cancer Center
Phase 2 Completed
NCT00469209 2020-09-24
Velcade, Trisenox, Vitamin C and Melphalan for Myeloma Patients
M.D. Anderson Cancer Center
Phase 1/2 Completed
NCT02868151 2019-03-20
Effect of Oral Vitamin C in Assessing the Severity of Oral Mucositis in Chemoradiation of Head and Neck Cancers
Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre
Phase 2/3 Completed
NCT02655913 2018-11-30
VCONSCLC
Clifford Hospital, Guangzhou, China
Phase 1/2 Completed
NCT02877277 2018-09-24
EVITA-Pilot
Rigshospitalet, Denmark
Phase NA Completed
NCT00228319 2018-06-19
Treatment of Newly Diagnosed Ovarian Cancer With Antioxidants
University of Kansas Medical Center
Phase 1/2 Completed
NCT00270647 2018-02-28
PHS II
Brigham and Women's Hospital
Phase NA Completed
NCT01715597 2017-10-31
Study on the Effect of Intravenous Ascorbic Acid on Intraoperative Blood Loss in Women With Uterine Myoma
Seoul National University Hospital
Phase 3 Completed
NCT01898091 2017-03-06
OM
Medical University of South Carolina
Phase 2 Completed
NCT00006021 2016-12-15
Arsenic Trioxide Plus Vitamin C in Treating Patients With Recurrent or Refractory Multiple Myeloma
University of Miami
Phase 1/2 Completed
NCT01032031 2016-03-08
The Effect of Green Tea and Vitamin C on Skin Health
University of Manchester
Phase NA Completed
NCT00284427 2016-02-10
Safety of Antioxidants During GYN Cancer Care
University of Kansas Medical Center
Phase 2 Completed
NCT01080352 2015-03-26
Vitamin C as an Anti-cancer Drug
Copenhagen University Hospital at Herlev
Phase 2 Completed
NCT02248584 2014-09-25
VITAMIN E, C and ZINC IN PATIENTS WITH SKIN CANCER: INFLUENCE ON OXIDATIVE STRESS AND INFLAMMATORY STATE
University of Campinas, Brazil
Phase NA Completed
NCT00317811 2013-11-06
Bortezomib, Ascorbic Acid, and Melphalan in Treating Patients With Newly Diagnosed Multiple Myeloma
National Cancer Institute (NCI)
Phase 2 Completed
NCT01050621 2013-06-21
Trial of Chemotherapy Plus Intravenous Vitamin C in Patients With Advanced Cancer for Whom Chemotherapy Alone is Only Marginally Effective
Jewish General Hospital
Phase 1/2 Completed
NCT00671697 2013-06-04
Decitabine, Arsenic Trioxide and Ascorbic Acid for Myelodysplastic Syndromes and Acute Myeloid Leukemia
Washington University School of Medicine
Phase 1 Completed
NCT00258245 2013-04-29
Arsenic Trioxide and Ascorbic Acid Combined With Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia
Barbara Ann Karmanos Cancer Institute
Phase 1 Completed
NCT00441207 2013-04-23
Study of High-Dose Intravenous (IV) Vitamin C Treatment in Patients With Solid Tumors
Midwestern Regional Medical Center
Phase 1 Completed
NCT00661544 2013-03-04
Arsenic Trioxide With Ascorbic Acid and Melphalan for Myeloma Patients
M.D. Anderson Cancer Center
Phase 1/2 Completed
NCT00272428 2009-12-17
Primary Prevention Trial of the Health Effects of Antioxidant Vitamins and Minerals.
Institut National de la Santé Et de la Recherche Médicale, France
Phase 3 Completed